Programme

Fresh from the lab, gummy nutrition brand Nourish3d is developing a breakthrough natural formulation designed to help trigger satiety for consumers. In this exclusive session, founder and CEO Melissa Snover lifts the lid on what’s inside, who it’s for, and how this innovation could reshape the weight management market.

Canola protein isolate stands out as a nutritious, sustainable and highly functional ingredient. In this presentation, dsm-firmenich unveils how the versatility of its Vertis CanolaPRO makes it ideal for products like bars and beverages, as well as many other formats designed to support weight management and healthier lifestyles.

First fat was the villain. Then sugar. Later, carbs and grains took the blame. Diet strategies have shifted dramatically over the decades, reflecting changing science, culture, and society. In this session, Dr Rachel Rich of Leeds Beckett University explores the fascinating history of weight-loss approaches - and how they set the stage for today’s GLP-1 era.

Plant proteins are packed with potential, but lingering off-notes often hold them back from mainstream appeal. Discover how dsm-firmenich is redefining taste with its innovating masking solutions: ModulaSENSE. This session reveals how science and flavour expertise combine to turn nutrition into products consumers truly crave.

Curious what it feels like to be on a GLP-1 drug? In this candid session, real users share their firsthand experiences - the highs, the lows, and the surprises no one warned them about. From changes in appetite and taste to the side effects people don’t often talk about, this is your inside look at life on the new wave of weight-loss drugs.

Satiety is more than a feeling – it’s a physiological response shaped by ingredients, texture, and timing. In this science-forward session, Ingredion’s Junrui Cheng, PhD, explains how hunger is measured, what satiety means, and how brain-gut research reveals texture’s role in eating rate and satisfaction. Learn how fibres and protein can help design foods that support weight wellness and consumer satisfaction.

As GLP-1 use rises, so do concerns about hidden nutrient gaps. Which deficiencies are most concerning to experts, and what risks does long-term use pose for overall wellbeing? In this session, we’ll explore the latest insights and highlight where food innovation can step in to close the gaps.

What’s next for obesity medications as the market evolves? We sit down with UC Davis academic Kimberly Fisher to explore how the arrival of oral GLP-1 pills, falling prices, and expiring patents could reshape not only drug adoption but also consumer behavior - and even what ends up in the shopping basket.

GLP-1 medications are reshaping how consumers think about food, raising questions about needs on them, coming off, or seeking alternatives. Dr. Jamy Ard shares clinic insights while Ingredion’s Kirstie Canene-Adams highlights nutrient-dense solutions with sugar reduction, fibre, and protein. Learn how brands can support appetite, weight maintenance, and wellness across the GLP-1 journey.

GLP-1s are changing how people experience food: what they crave, what they buy, how they talk about eating, and the choices they make every day. This session looks closely at the consumer lens: what’s truly shifting in behavior, what remains constant, and how these patterns reveal the future of food culture. Get a front-row seat to what’s changing, what’s sticking, and what it means for your business.

As GLP-1 medications reshape consumer behaviour, food and beverage brands are racing to adapt – but what can they say in marketing? In this masterclass, Ingredion's Kirstie Canene-Adams, PhD, explains the claims landscape for products targeting GLP-1 users and alternatives. From nutrient content to "GLP-1 friendly" messaging, learn how to build claims that resonate with consumers and regulators.

GLP-1 users have new nutritional needs, and Nestlé Health Science is ready to meet them. After overcoming complex formulation challenges, the company has developed a high-protein drink built for weight management and long-term wellness. Find out how it came together – and what’s coming next.

Spikes and crashes – the “glucose rollercoaster” – are fuelling fresh interest in nutrition strategies that support steadier blood sugar via the incretin effect (aka GLP-1 & GIP). Join two Rousselot experts as they explore how emerging science is translated into everyday products, and what it could mean for the future of glucose management.

Imagine nutrients delivered not in one quick burst, but released steadily over time – fuelling the body exactly when it needs them. This is the promise of nutrient timing, a breakthrough in food tech designed to support GLP-1 users throughout their weight-loss journey. But can the science scale? And will consumers embrace the idea of “slow nutrition”?

For decades, food and drink marketing has leaned heavily on indulgence – think cravings, cheat days and irresistible treats. But as consumers grow more mindful about health, sustainability and purpose, manufacturers are being forced to rethink their messaging. So how are brands shifting from selling desire on the shelves to function?